Global Neuroprosthetics Market is expected to Witness High Growth Owing to increasing cases of neurological disorders

Global Neuroprosthetics Market Demand 

Neuroprosthetics is a branch of neural engineering that aims to design neural prosthetic medical devices that could treat various neurological conditions such as Alzheimer's, Parkinson's disease, epilepsy, and diabetes. Neuroprosthetics includes devices like cochlear implants that are surgically implanted and provide a sense of sound to a deaf person. The advancement and development of novel microsystem technologies has enabled the development of brain-computer interfaces that can restore mobility, repair physical injuries, and provide communications options for people with impairments. Neuroprosthetics work by detecting signals from the brain or peripheral nerves and converting them into artificial sensory feedback or motor commands. The ability of neuroprosthetics to help people compensate for or overcome neurological conditions has generated tremendous demand from patients.

The Global Neuroprosthetics Market is estimated to be valued at US$ 12.66 Bn in 2024 and is expected to exhibit a CAGR of 10% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the Global Neuroprosthetics market are Second Sight, Med-El, Retina Implant, Sonova Holding AG., NeuroPace, Inc., Nevro, Medtronic plc, Abbott, Cochlear, Boston Scientific Corporation, Livanova, Demant A/S, Cyberonics Inc. and NDI Medical LLC. These players are focusing on developing innovative Global Neuroprosthetics Market Demand devices through increased R&D spending.

There is a huge opportunity for neuroprosthetics in restoring sensory and motor functions damaged by conditions like spinal cord injury and stroke. Advancements in brain-machine interface technologies will help provide more affordable assistive devices to patients.

North America dominates the global neuroprosthetics market. However, Asia Pacific region is expected to offer high growth opportunities owing to rising healthcare infrastructure and increasing healthcare expenditure. Key players are expanding their presence in Asia Pacific to tap the growth potential in developing nations.

Market Drivers
Increasing prevalence of neurological disorders like Parkinson's disease, epilepsy, and spinal cord injuries are a key factor driving the demand for neuroprosthetic devices globally. According to WHO, over 50 million people worldwide suffer from epilepsy. The rising geriatric population will further propel the incidence of neurological conditions necessitating neuroprosthetics interventions.

Market Restraints

High cost of neuroprosthetic devices remains a major challenge restricting their widespread adoption, especially in developing nations. Significant research gap exists in understanding the brain and developing interfaces for complex neurological repairs. Stringent regulations regarding the safety and efficacy of neuroprosthetic devices also impede market growth. Limited reimbursement policies further discourage the use of costly neuroprosthetics treatments.

Segment Analysis

The global neuroprosthetics market is dominated by auditory neuroprosthetics segment as there are established diagnostic and treatment solutions for hearing impairment globally. Majority of people suffering from hearing loss opt for cochlear implants which help in improving hearing. Development of advanced and miniaturized speech processors along with implanted coils has led to preference for cochlear implants. Visual neuroprosthetics segment is expected to witness highest growth during the forecast period due to ongoing research for restoration of vision and clinical trials of visual prostheses.

Global Analysis

North America dominates the global neuroprosthetics market due to presence of major players, high awareness levels regarding novel treatment options and availability of advanced healthcare facilities. However, Asia Pacific is fastest growing region on account increasing prevalence of neurological disorders, rising healthcare expenditure and technological advancements in developing economies. Major players are investing in this region by setting up manufacturing plants in countries such as India and China to cater growing demand. Also, presence of large patient pool makes Asia Pacific lucrative market for key participants. Europe holds significant share in global market and is expected to retain its dominance during the forecast period supported by presence of countries with well established medical infrastructure.

Get More Insights On- Global Neuroprosthetics Market Demand 

Comments

Post a Comment

Popular posts from this blog

Plasma Fractionation: The Process of Separating Blood Plasma into Useful Components

Image
  Plasma Fractionation What is Plasma Fractionation? Plasma fraction is the process of separating the different components of blood plasma through various physico-chemical processes like molecular size filtration, precipitation, chromatography and crystallization. Blood plasma, the liquid part of blood, contains thousands of proteins, antibodies, clotting factors and other components which help maintain homeostasis in the body. Plasma Fraction enables isolation of specific plasma proteins on a large scale which are then used to manufacture life-saving plasma derived medicines, diagnostics and medical therapies. Methods used in Plasma Fractionation Several specialized techniques are employed for separating the individual components from pooled donor plasma with high precision and purity. These include: - Cryoprecipitation: Based on temperature-dependent solubility, this involves cooling plasma gradually until certain proteins like Plasma Fractionation precipitate out. The su...
Read more

Theranostics: Transforming the Landscape of Personalized Medicine Innovative Approaches and Groundbreaking Advancements

Image
  Theranostics What is Theranostics? Theragnostics refers to an emerging field in medicine that combines therapeutic and diagnostic capabilities into single agents or platforms. The goal of theragnostics is to provide personalized patient care by selecting appropriate targeted therapies and monitoring their effectiveness. This novel approach has the potential to significantly improve treatment outcomes for many illnesses by matching therapies to individual molecular profiles. Theranostic Agents and Theranostics Theranostics relies on the development of agents and technologies that can both detect specific molecular abnormalities and targets within the body as well as deliver targeted therapies to those same areas. Some examples of theranostic platforms currently under investigation include: - Theranostic Nanoparticles: Nanoparticles are being engineered to incorporate both diagnostic imaging agents like fluorophores as well as targeted drug payloads. These "smart particles...
Read more

Mometasone Furoate Market is Anticipated to Witness High Growth Owing to Growing Prevalence of Allergic Diseases

Image
Mometasone Furoate Market Size Mometasone furoate is a synthetic corticosteroid applied topically to treat conditions such as eczema, psoriasis and dermatitis. It works by reducing inflammation and itching of the skin. It comes as a cream or ointment applied to the skin. Mometasone furoate products are used to treat flare-ups and reduce symptoms of allergic skin conditions. Growing prevalence of allergic diseases such as asthma, allergic rhinitis and atopic dermatitis across the world has increased the demand for anti-allergic medications including mometasone furoate products. The Global mometasone furoate market is estimated to be valued at US$ 1467.01 Bn in 2024 and is expected to exhibit a CAGR of 22.% over the forecast period 2024 To 2031. Key Takeaways Key players operating in the mometasone furoate market are Thermo Fisher Scientific, Merck KGaA, Danaher Corporation, Lonza Group, Miltenyi Biotec, Takara Bio Group, CellGenix GmbH, FUJIFILM Irvine Scientific, Agilent Technol...
Read more